Tg(Cldn11-cre/ERT2)151Tmak
Transgene Detail
|
Symbol: |
Tg(Cldn11-cre/ERT2)151Tmak |
Name: |
transgene insertion 151, Taija Makinen |
MGI ID: |
MGI:6727043 |
Synonyms: |
Cldn11-CreERT2 |
Transgene: |
Tg(Cldn11-cre/ERT2)151Tmak Location: unknown
|
Alliance: |
Tg(Cldn11-cre/ERT2)151Tmak page
|
|
|
Transgene Type: |
|
Transgenic (Inducible, Recombinase) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Tg(Cldn11-cre/ERT2)151Tmak expression driven by
1 gene
Transgene expression driven by:
Organism |
Driver Gene |
Note |
mouse |
Cldn11 (MGI:106925) |
|
|
|
|
Mutation details: The transgene contains the BAC RP23-128D19 with the cre recombinase fusion to the modified estrogen receptor (ERT2) inserted downstream of the translation initiation codon. Five transgenic founder lines were generated with one (line 151) showing specific cre activity in the lymphatic valve was established for further studies.
(J:308453)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Cldn11
(mouse)
|
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:308453 Ortsater H, et al., An inducible Cldn11-CreERT2 mouse line for selective targeting of lymphatic valves. Genesis. 2021; |
All: |
3 reference(s) |
|